4//SEC Filing
MANNING MARTHA E 4
Accession 0001415889-24-004781
CIK 0001267813other
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 4:05 PM ET
Size
5.7 KB
Accession
0001415889-24-004781
Insider Transaction Report
Form 4
MANNING MARTHA E
SVP, GEN. COUNSEL & CORP. SEC.
Transactions
- Sale
Common Stock
2024-02-20$9.57/sh−1,894$18,126→ 52,966 total
Footnotes (2)
- [F1]The sales reported on this Form 4 represent shares of common stock of Marinus Pharmaceuticals, Inc. (the "Company") sold by the reporting person pursuant to a Rule 10b5-1 Plan adopted on May 16, 2022 to cover tax obligations in connection with the vesting of restricted stock units.
- [F2]The price reported in column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $9.07 to $9.78, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.
Documents
Issuer
MARINUS PHARMACEUTICALS, INC.
CIK 0001267813
Entity typeother
Related Parties
1- filerCIK 0001227894
Filing Metadata
- Form type
- 4
- Filed
- Feb 21, 7:00 PM ET
- Accepted
- Feb 22, 4:05 PM ET
- Size
- 5.7 KB